Cargando…

The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial

BACKGROUND: To improve risk factor management in diabetes, we need to support effective interactions between patients and healthcare providers. Our aim is to develop and evaluate a treatment decision aid that offers personalised information on treatment options and outcomes, and is intended to empow...

Descripción completa

Detalles Bibliográficos
Autores principales: Denig, Petra, Dun, Mathijs, Schuling, Jan, Haaijer-Ruskamp, Flora M, Voorham, Jaco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561233/
https://www.ncbi.nlm.nih.gov/pubmed/23171524
http://dx.doi.org/10.1186/1745-6215-13-219
_version_ 1782257933620346880
author Denig, Petra
Dun, Mathijs
Schuling, Jan
Haaijer-Ruskamp, Flora M
Voorham, Jaco
author_facet Denig, Petra
Dun, Mathijs
Schuling, Jan
Haaijer-Ruskamp, Flora M
Voorham, Jaco
author_sort Denig, Petra
collection PubMed
description BACKGROUND: To improve risk factor management in diabetes, we need to support effective interactions between patients and healthcare providers. Our aim is to develop and evaluate a treatment decision aid that offers personalised information on treatment options and outcomes, and is intended to empower patients in taking a proactive role in their disease management. Important features are: (1) involving patients in setting goals together with their provider; (2) encourage them to prioritise on treatments that maximise relevant outcomes; and (3) integration of the decision aid in the practice setting and workflow. As secondary aim, we want to evaluate the impact of different presentation formats, and learn more from the experiences of the healthcare providers and patients with the decision aid. METHODS AND DESIGN: We will conduct a randomised trial comparing four formats of the decision aid in a 2×2 factorial design with a control group. Patients with type 2 diabetes managed in 18 to 20 primary care practices in The Netherlands will be recruited. Excluded are patients with a recent myocardial infarction, stroke, heart failure, angina pectoris, terminal illness, cognitive deficits, >65 years at diagnosis, or not able to read Dutch. The decision aid is offered to the patients immediately before their quarterly practice consultation. The same decision information will be available to the healthcare provider for use during consultation. In addition, the providers receive a set of treatment cards, which they can use to discuss the benefits and risks of different options. Patients in the control group will receive care as usual. We will measure the effect of the intervention on patient empowerment, satisfaction with care, beliefs about medication, negative emotions, health status, prescribed medication, and predicted cardiovascular risk. Data will be collected with questionnaires and automated extraction from medical records in 6 months before and after the intervention. DISCUSSION: This decision aid is innovative in supporting patients and their healthcare providers to make shared decisions about multiple treatments, using the patient’s data from electronic medical records. The results can contribute to the further development and implementation of electronic decision support tools for the management of chronic diseases. TRIAL REGISTRATION: Dutch Trial register NTR1942.
format Online
Article
Text
id pubmed-3561233
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35612332013-02-04 The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial Denig, Petra Dun, Mathijs Schuling, Jan Haaijer-Ruskamp, Flora M Voorham, Jaco Trials Study Protocol BACKGROUND: To improve risk factor management in diabetes, we need to support effective interactions between patients and healthcare providers. Our aim is to develop and evaluate a treatment decision aid that offers personalised information on treatment options and outcomes, and is intended to empower patients in taking a proactive role in their disease management. Important features are: (1) involving patients in setting goals together with their provider; (2) encourage them to prioritise on treatments that maximise relevant outcomes; and (3) integration of the decision aid in the practice setting and workflow. As secondary aim, we want to evaluate the impact of different presentation formats, and learn more from the experiences of the healthcare providers and patients with the decision aid. METHODS AND DESIGN: We will conduct a randomised trial comparing four formats of the decision aid in a 2×2 factorial design with a control group. Patients with type 2 diabetes managed in 18 to 20 primary care practices in The Netherlands will be recruited. Excluded are patients with a recent myocardial infarction, stroke, heart failure, angina pectoris, terminal illness, cognitive deficits, >65 years at diagnosis, or not able to read Dutch. The decision aid is offered to the patients immediately before their quarterly practice consultation. The same decision information will be available to the healthcare provider for use during consultation. In addition, the providers receive a set of treatment cards, which they can use to discuss the benefits and risks of different options. Patients in the control group will receive care as usual. We will measure the effect of the intervention on patient empowerment, satisfaction with care, beliefs about medication, negative emotions, health status, prescribed medication, and predicted cardiovascular risk. Data will be collected with questionnaires and automated extraction from medical records in 6 months before and after the intervention. DISCUSSION: This decision aid is innovative in supporting patients and their healthcare providers to make shared decisions about multiple treatments, using the patient’s data from electronic medical records. The results can contribute to the further development and implementation of electronic decision support tools for the management of chronic diseases. TRIAL REGISTRATION: Dutch Trial register NTR1942. BioMed Central 2012-11-21 /pmc/articles/PMC3561233/ /pubmed/23171524 http://dx.doi.org/10.1186/1745-6215-13-219 Text en Copyright ©2012 Denig et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Protocol
Denig, Petra
Dun, Mathijs
Schuling, Jan
Haaijer-Ruskamp, Flora M
Voorham, Jaco
The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial
title The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial
title_full The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial
title_fullStr The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial
title_full_unstemmed The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial
title_short The effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (PORTDA-diab): study protocol for a randomised controlled trial
title_sort effect of a patient-oriented treatment decision aid for risk factor management in patients with diabetes (portda-diab): study protocol for a randomised controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3561233/
https://www.ncbi.nlm.nih.gov/pubmed/23171524
http://dx.doi.org/10.1186/1745-6215-13-219
work_keys_str_mv AT denigpetra theeffectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT dunmathijs theeffectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT schulingjan theeffectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT haaijerruskampfloram theeffectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT voorhamjaco theeffectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT denigpetra effectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT dunmathijs effectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT schulingjan effectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT haaijerruskampfloram effectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial
AT voorhamjaco effectofapatientorientedtreatmentdecisionaidforriskfactormanagementinpatientswithdiabetesportdadiabstudyprotocolforarandomisedcontrolledtrial